← Back to Search

Behavioral Intervention

dCBI for Inflammatory Bowel Disease

N/A
Waitlist Available
Led By Sandra Kim, MD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Summary

This trial will test a modified version of RxWell, which will include chronic disease management and transition readiness, to see if it is effective for patients ages 16-25.

Eligible Conditions
  • Inflammatory Bowel Disease
  • Mental Health Issue

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in anxiety severity over time
Mental Depression
Secondary outcome measures
Change in Transition Readiness to Adult Care

Trial Design

1Treatment groups
Experimental Treatment
Group I: Digital Cognitive Behavioral Intervention (DCBI)Experimental Treatment1 Intervention
The dCBI, RxWell, is a trans cognitive behavioral therapy (CBT) mobile app product addressing depression and anxiety that was developed based on standard CBT techniques.

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,737 Previous Clinical Trials
16,339,250 Total Patients Enrolled
Sandra Kim, MDPrincipal InvestigatorUniversity of Pittsburgh
~2 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top